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Differences in Bone Mineral Density between the Right and Left 
Hips in Postmenopausal Women
Bone mineral density (BMD) using dual energy radiography absorptiometry are commonly 
used for the diagnosis of osteoporosis. It is usually measured at the spine and also at one 
hip joint. Controversy still exists regarding the use of bilateral hip scanning. We analyzed 
the difference of BMD at bilateral hips in 384 postmenopausal women, retrospectively. The 
concordance and discordance rates of the lowest T-score and BMD between both hips were 
evaluated. The BMDs of the femoral neck and trochanter were significantly different 
between both hips (P < 0.05). There were also discrepancies between the lowest T-scores 
of both hips (P < 0.05). The discordance rates were about 30%. Due to significant 
differences in BMD between both hips at the femoral neck and trochanter and high 
discordance rate, bilateral hip measurements using DEXA are recommended to avoid 
underestimating osteoporosis.
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ORIGINAL ARTICLE
Musculoskeletal Disorders
INTRODUCTION
Bone densitometry measurements are conducted for many 
reasons, such as evaluations of fracture risk in old age. The World 
Health Organization (WHO) introduced three diagnostic cate-
gories (normal, osteopenic and osteoporotic bone) for the in-
terpretation of bone mineral density (BMD) (1). BMD measure-
ments by dual energy radiography absorptiometry (DEXA) are 
used for the diagnosis of osteoporosis. Bone densities are usu-
ally measured at the lumbar spine (L1-4) and hip joints to grade 
the severity of osteoporosis by the lowest T-score. Unilateral mea-
surements of proximal femoral BMD are typically performed to 
minimize time, medical costs and radiation exposure that is as-
sociated with radiography (2). Minimal differences of bilateral 
proximal femoral BMD are assumed (2-5). However, some au-
thors have observed BMD variation in opposing femora by DEXA 
measurements (6, 7). Furthermore, unilateral hip disorders, such 
as arthritis, hemiplegia, Paget’s disease, and fractures with or 
without implants, may affect BMD; it remains unclear whether 
symmetry of BMD in the proximal femur can be assumed (8-
10). Therefore, controversies exist regarding the use of bilateral 
hip scanning. As the diagnostic classification of osteoporosis is 
based solely on the lowest T-score at the spine and hip in most 
cases, interpretations could be affected by significant differenc-
es in hip BMDs between the left and right hips. The purpose of 
this study was to ascertain differences in BMD and the lowest 
T-score measurements of both hips in Korean women for the 
evaluation of osteoporosis using DEXA.
MATERIALS AND METHODS
Participants and methods 
This study was a retrospective cohort study. BMD data were 
collected from the Anam Hospital database. Postmenopausal 
women over 50 yr of age were eligible for the study if the follow-
ing criteria were met: 1) measurements performed between 1 
January 2007 and 31 December 2010 and 2) anatomical struc-
tures that were suitable for DEXA scanning. Exclusion criteria 
included diseases affecting calcium homeostasis (i.e., hyper-
parathyroidism or hypoparathyroidism, hyperthyroidism or hy-
pothyroidism, hypocalcemia, rheumatoid arthritis, Paget’s dis-
ease, osteomalacia, and serum creatinine levels greater than 1.7 
mg/dL) and cancer. 
Measurement of bone mineral density 
The BMDs of both femoral necks, intertrochanteric areas and 
total BMD were measured on the same day using a Hologic Dis-
covery W dual-energy x-ray absorptiometry (Hologic, Inc., Bed-Hwang HJ, et al.  •  Bone Mineral Density Differences between Right and Left Hips
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ford, MA, USA). Adult whole body software (QDR V. 12.1) was 
used for data acquisition and analysis. Bone mineral densities 
were expressed as grams per square centimeter (g/cm
2). The 
results of measurements for the femoral neck, trochanteric area, 
intertrochanteric area, and total hip were collected. Ward’s tri-
angle data were excluded. Bone status was determined by the 
lowest T-score. Cases were classified as normal, osteopenic bone, 
osteoporotic bone, or severely osteoporotic bone according to 
WHO criteria.
Other variables 
Additional covariates were obtained from data collected con-
currently with BMD measurements and included age, height 
(cm), weight (kg), and BMI (kg/m
2). Using BMI scores, we clas-
sified women as low weight (BMI  < 20), normal (20  ≤ BMI  < 25) 
and overweight (25  ≤ BMI).
Statistical analysis
Statistical analyses were performed with the Statistical Package 
for the Social Sciences (SPSS) V.18 software. Results are pre-
sented as means ± SDs. The Wilcoxon signed ranks test was 
used to compare BMD measurements between the right and 
left hips. Analyses of covariance (ANCOVA) were used to deter-
mine the influences of age, height, weight, and BMI on differ-
ences between BMD and lowest T-score measurements. For all 
statistical comparisons, P values  < 0.05 were considered sig-
nificant.
Ethics statement
This retrospective study was reviewed and approved by the in-
stitutional review board of Korea University Anam Hospital (IRB 
No. AN11036-001). Informed consent was waived by the board 
due to the study design.
RESULTS
Three hundred eighty four women were enrolled in this study. 
The mean age was 69.5 ± 9.0 yr, and the mean height, weight 
and BMI were 151.9 ± 5.6 (cm), 55.04 ± 9.1 (kg), and 23.3 ± 3.5 
(kg/m
2), respectively. We compared bilateral BMD (g/cm
2) at 
different parts of the femur (Table 1). There were significant dis-
cordances of the neck and trochanteric area measurements  
between the right and left hips according to the Wilcoxon signed 
ranks test (P < 0.05). Other areas of the hip and the lowest T-
scores did not differ significantly.
  When included as a BMI covariate, ANCOVA indicated that 
the lowest T-scores differed significantly between the right and 
left hips (P = 0.018). Other covariates, age, height, and weight 
did not have a significant influence on T-score in ANCOVA. The 
values shown in Table 2 represent the means ± SDs and distri-
butions of the lowest T-scores assigned to each BMI group. Fig. 1 
is a box-whisker plot based on Table 2 that shows median values, 
interquartile range, spread, and outlying values for the lowest 
T-scores in the three groups. As BMI increased, the median T-
score value increased.
  The distribution according to WHO classification of osteopo-
rosis and concordance rates between the lowest T-scores of both 
hips are shown in Table 3. The lowest T-scores were concordant 
between hips in a total of 70.9% of the women. The rest of the 
women (n = 112, 29.1%) would have been at risk of misdiagno-
sis provisionally if only unilateral BMD measurements had been 
taken. Among these patients, 62 (16.3%) would have been clas-
sified as having normal or only osteopenic bone mineral densi-
ty if we had merely scanned them unilaterally. These groups are 
Table 1. Bone mineral density of both hips
Site in the femur
Right hip  
BMD (g/cm
2) 
(n = 384)
Left hip  
BMD (g/cm
2) 
(n = 384)
P value
Neck 0.533 ± 0.15 0.551 ± 0.11     0.008*
Trochanter 0.519 ± 0.10 0.516 ± 0.09 < 0.001*
Intertrochanter 0.838 ± 0.17 0.843 ± 0.17 Ns
Total 0.693 ± 0.16 0.697 ± 0.17 Ns
Data are expressed as mean ± standard deviation. Statistical analysis was performed 
using Wilcoxon signed ranks test. *P < 0.05. Ns, not significant.
Table 2. Lowest T-score of each BMI Group
Lowest T-score
BMI group
< 20 (n = 53) 20-25 (n = 209) > 25 (n = 122)
Right  -2.39 ± 0.99 -0.84 ± 1.76 -1.47 ± 1.11
Left   -2.38 ± 0.98 -1.90 ± 1.10 -1.50 ± 1.11
The values represent means ± SDs.
Fig. 1. Box and whisker plot. A box-whisker plot, based on Table 2, that shows medi-
an values, interquartile range, spread, and outlying values for the lowest T-scores in 
the three groups. There are differences of interquartile range at each group. The me-
dian values are increasing with the increasing of BMI.
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important because they would have not received treatment for 
osteoporosis based upon just one score according to the WHO 
criteria. Fifteen patients (3.9%) who were diagnosed as having 
normal bone density actually had osteopenia; and 35 (9.1%) 
severely osteoporotic patients were underdiagnosed as simply 
having osteoporosis. 
DISCUSSION
In our study, a significant bilateral difference in hip BMD (g/cm
2) 
was identified at the neck and trochanter areas. We also con-
firmed that BMI could influence the difference between bilat-
eral hip BMD measurements; as BMI increased, the median T-
score also tended to increase. To put the issue into a clinical per-
spective, we usually use the lowest T-scores to determine pa-
tients’ bone health according to the WHO classification. In our 
study, the lowest T-scores were discordant between hips in 30% 
of participants and about 17% would have missed the chance 
to be treated for osteoporosis due to underestimation. Patients 
could be classified differently if only one normal or osteopenic 
hip is scanned but the osteoporotic or severely osteoporotic con-
tralateral hip is not.
  The reasons for the discordance of bilateral hip BMD can in-
clude genetic variation, immobilization, pathology such as os-
teoarthritis, stroke etc. (11, 12). Dominance of extremity can be 
another reason. Moreover, aerobic and strength training exer-
cise can also make the skeletal system stronger. Krahl et al. (13) 
reported the professional tennis player could develop a stronger 
and bigger skeleton and a higher BMD in the dominant stroke 
arm. 
  However, a controversy exists regarding the clinical use of  
bilateral hip scans. Petley et al. (14) reported that only 3.3% pa-
tients in whom one side was osteoporotic had other sides and/
or spine measurements that were normal or osteoporotic. Many 
authors agreed with this opinion. They insist that there is only a 
small benefit in performing bilateral femoral neck BMD mea-
surements (15, 16). In contrast, Lilley et al. (7) revealed that the 
range of BMD differences between the femora was large; for 
some individuals, the BMD values differed by up to 35% in the 
femoral neck, 64% in Ward’s triangle and 80% in the trochanter. 
They recommend routine scanning of both femora (7). We also 
observed a difference in bilateral BMDs at the femur neck and 
trochanteric area (P < 0.05).
  The authors who were in opposition to bilateral scanning of 
BMD have mentioned that it is a time-consuming and costly 
procedure. Clinically, measuring BMD at the hip was made pos-
sible with the introduction of dual-photon absorptiometry (DPA) 
in the early 1980s (17). However, the scan time for a single hip 
was 20 min or more, so it was not practical to consider bilateral 
hip scans in clinical practice. This lengthy time is the reason the 
practice of scanning only one hip remains the standard densi-
tometry procedure in most large centers. With the advent of suc-
cessive generations of scanning systems (such as DEXA), how-
ever, scan times have become much shorter. A single hip scan 
can be easily completed in a few minutes in automated sequen-
tial bilateral hip mode; the second hip adds only 60 sec, and both 
hips can be scanned in five minutes unless patient positioning 
needs to be adjusted. Therefore, the ability to perform bilateral 
hip scans is no longer constrained by time issues. Under the 
Korea National Health Service, patients pay the same price for 
routine scanning, which includes the L-spine and one femur, as 
they pay for scanning of the L-spine and both femurs. Thus, bi-
lateral hip BMD scanning is no longer a time-consuming, or 
costly procedure.
  Clinically, we gained some advantages from bilateral BMD 
monitoring. Bisphosphonate may induce insufficiency fractures 
in the subtrochanteric area. Alendronate, an inhibitor of bone 
resorption, is a drug widely used in osteoporosis treatment. 
However, concerns have been raised recently about potential 
over suppression of bone turnover during long-term use. Many 
patients receiving bisphosphonates for the treatment of osteo-
porosis have sustained atypical subtrochanteric femoral frac-
tures (and sometimes simultaneous bilateral fractures) follow-
ing low-energy trauma (18-21). Patients who take osteoporosis 
medication should have their bone mineral density checked 
regularly to retain approval of insurance coverage in Korea. In 
this situation, we can use the films for BMD measured by DEXA 
as a screening tool for cortical thickening at the subtrochanteric 
area without additional femur radiographs. As noted above, in-
sufficiency fractures can develop bilaterally. BMD scanning is 
very beneficial, especially for patients who have taken bisphos-
phonate medications for years.  
  Over the past several years, a series of meta-analyses has been 
performed to identify risk factors for osteoporotic fracture and 
to determine their dependence upon age, sex and BMD (22-25). 
A fracture risk assessment tool (FRAX
TM) was developed based 
upon the use of clinical risk factors both with or without BMD 
tests applied. This tool has been widely applied and studied in 
Korea (26). We can easily calculate a patient’s risk automatically 
by inputting patient data into the tool. The data include the fol-
lowing variables: patient age, sex, height, weight, previous frac-
Table 3. Concordance according to the lowest T-score
 G1L  G2L  G3L  G4L
G1R  31 (8.1%)   9 (2.3%) 0 (0%)    1 (0.3%)
G2R    6 (1.6%) 119 (31.0%)  29 (7.6%)    3 (0.8%)
G3R 0 (0%) 25 (6.5%) 43 (11%)  18 (4.7%)
G4R 0 (0%)   4 (1.0%)  17 (4.4%) 79 (21%)
Numbers represent women at each group. Numbers in parenthesis refer to each per-
centage of all women. Italic & bold numbers represent ‘Concordance’ that shows   
patients and percentage in the same criteria according to WHO classification. G1, 
normal; G2, osteopenia; G3, osteoporosis; G4, severe osteoporosis; R, right side; L, 
left side. Hwang HJ, et al.  •  Bone Mineral Density Differences between Right and Left Hips
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ture history, parental history of hip fracture, current tobacco 
smoking, use of oral glucocorticoids, rheumatoid arthritis, other 
causes of secondary osteoporosis, and daily alcohol consump-
tion. The tool has used the femoral neck site measured with 
DEXA as the reference standard for diagnosis of osteoporosis 
based upon a T-score of - 2.5 SD or lower using a standardized 
reference population and femoral neck BMD. FRAX algorithms 
give the ten-year probability of hip fracture and the ten-year prob-
ability of a major osteoporotic fracture, including fractures of 
the spine, forearm, hip, or shoulder. Having data for the femoral 
neck BMD is essential when using the algorithm. Differences in 
neck BMD between the right and left sides could influence the 
results. For example, in our cohort, a 72-yr-old female patient 
(156 cm, 62 kg) had a 0.603 g/cm
2 right femur neck BMD and a 
0.512 g/cm
2. The calculated results were a 2.7% ten-year proba-
bility of hip fracture and an 8.3% ten-year probability of a major 
osteoporotic fracture based upon the right side BMD. Using the 
BMD of the left side, we found that a patient had a 5.8% ten-year 
probability of hip fracture and a 13% ten-year probability of a 
major osteoporotic fracture. These results would mean that we 
could have obtained inaccurate data from FRAX if her BMD 
scanning had been done unilaterally. We can go even further 
and derive a comparison of FRAX probabilities where the BMD 
input is based upon the lumbar spine T-score, minimum T-
score (lumbar spine or bilateral femoral neck) and weighted 
mean T-score (lumbar spine or femoral neck or trochanter area). 
This method will help narrow the proper choice of BMD input 
to the FRAX model and therefore improve estimates of risk clas-
sification.
  There were a few of limitation of our study. First, it looked at 
only one measurement. Follow up measurement would be nec-
essary and could make up for a defect. Second, we limited range 
of investigation because most of BMD were taken in postmeno-
pausal women to evaluate osteoporosis. Further evaluation in-
cluding bilateral BMD check in all age group and sex should be 
performed to reflect precision.
  Finally, as mentioned above, BMD discordance on upper ex-
tremity according to side dominance is very interesting. That 
dominance on lower extremity may have a same influence. Un-
fortunately, however in this study, side dominance of lower ex-
tremity was not included. The study about effect of side domi-
nance at proximal femur BMD will be necessary and may pro-
vide a more accurate and interesting result.
  In conclusion, we confirmed significant differences between 
hip BMD measurements at the femoral neck and trochanteric 
areas in a sample of postmenopausal women. We also observed 
discordance between the right and left hips in the lowest T-scores, 
which was more likely to occur with increasing BMI, and de-
tected many cases of potential underestimation of osteoporosis 
if only one hip measurement had been performed. These results 
suggest that treatment opportunities will be missed if only one 
hip is routinely scanned when evaluating postmenopausal wom-
en for osteoporosis. Additionally, we can use bilateral hip BMD 
data in other clinical areas as well. Therefore, bilateral hip mea-
surements using DEXA are recommended to avoid underesti-
mating the BMD status of postmenopausal women and to ex-
tend the application of BMD.
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